Search Results for “Get instant Success With SAP C-C4H630-34 Exam Questions [2024] 🎯 Simply search for 【 C-C4H630-34 】 for free download on ➥ www.pdfvce.com 🡄 🏃Exam C-C4H630-34 Flashcards” – Page 39

Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey

359

Bygum, A.+, Caballero, T., Grumach, A. S., Longhurst, H. J., Bouillet, L., Aberer, W., Zanichelli, A., Botha, J., Andresen, I., Maurer, M. for the IOS study group: Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the icatibant outcome survey. Clin. Transl. Allergy 2019: 9; 37. IF: 5.13

o.359

128.	Bygum, A., Busse, P., Caballero, T., and Maurer, M.+: Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema. Front. Med. 2017: 4; 212. IF: : 2.03

Diagnosis and treatment of urticaria and angioedema: a worldwide perspective

67.

Sánchez-Borges, M., Asero, R., Ansotegui, I. J., Baiardini, I., Bernstein, J. A., Canonica, G. W., Gower, R., Kahn, D. A., Kaplan, A. P., Katelaris, C., Maurer, M., Sim Park, H., Potter, P., Saini, S., Tassinari, P., Tedeschi, A., Min Ye, Y., Zuberbier, T., and the WAO Scientific and Clinical Issues Council: Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ. J. 2012: 5; 125-147. IF: N/A

r.067

159.	Saini, S., Shams, M., Bernstein, J. A., and Maurer, M.⁺: Urticaria and Angioedema across the ages. J. Allergy Clin. Immunol. Pract. 2020: 6; 1866-1874. IF: 8.86

r.159

104	Metz, M., Altrichter, S., Ardelean, E., Keßler, B., Krause, K., Magerl, M., Siebenhaar, F., Weller, K., Zuberbier, T., and Maurer, M.+: Anti-immunglobulin E treatment of patients with recalcitrant physical urticaria. Int. Arch. Allergy Immunol. 2011: 154; 177-180. IF: 2.40

206	Hawro, T., Zalewska, A., Hawro, M., Kaszuba, A., Królikowska, M., and Maurer M.+: Impact of psoriasis severity on family income and quality of life. J. Eur. Acad. Dermatol. Venereol. 2015: 29; 438-443. IF: TBD 2.82

208	Hawro, T., Bogucki, A., Krupińska-Kun, M., Maurer, M.+, and Woźniacka, A.: Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus. PLoS ONE 2015: 10; e0119911. IF: 3.05

o.208

15.	Zuberbier, T. and Maurer, M.: Antihistamines in the treatment of urticaria. In: Thurmond, R. L., editor: Histamine in inflammation. Texas: Springer Science + Business Media, LLC, Landes Bioscience, 2010

22.	Mullol, J., Bousquet, J., Bachert, C., Canonica, W. G., Gimenez-Arnau, A., Kowalski, M. L., Marti-Guadano, E., Maurer, M., Picado, C., Scadding, G., and van Cauwenberge, P.: Rupatadine in allergic rhinitis and chronic urticaria. Allergy 2008: 63; 5-28. IF: 6.20

292	Ohanyan, T., Schoepke, N., Eirefelt, S., Hoey, G., Koopmann, W., Hawro, T., Maurer, M. and Metz, M.+: Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof-of-concept, controlled trial with topical aprepitant. Acta Derm. Venereol. 2018: 98; 26-31. IF: 3.53

Results

Search Results for: Get instant Success With SAP C-C4H630-34 Exam Questions [2024] 🎯 Simply search for 【 C-C4H630-34 】 for free download on ➥ www.pdfvce.com 🡄 🏃Exam C-C4H630-34 Flashcards – Page 39

Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey

Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema

Diagnosis and treatment of urticaria and angioedema: a worldwide perspective

Urticaria and Angioedema across the ages

Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria

Impact of psoriasis severity on family income and quality of life

Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus

Antihistamines in the treatment of urticaria

Rupatadine in allergic rhinitis and chronic urticaria

Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof-of-concept, controlled trial with topical aprepitant